anti-VEGF treatment

DRUG3 trials

Sponsors

Azienda Ospedaliero-Universitaria Careggi, Bayer, Vastra Gotaland Region

Conditions

Age-Related Macular DegenerationDiabetes MellitusDiabetic Macular EdemaHyperglycaemia (Diabetic)Neovascular Age-related Macular DegenerationOxidative StressRetinal Vein OcclusionVEGF

Unknown Phase

Effect of Micronutrient Supplementation on the Intestinal Microbiota in Patients With Age-related Macular Degeneration - The Gut-Retina-axis Study

CompletedNCT06391411

Azienda Ospedaliero-Universitaria CareggiAge-Related Macular Degeneration

Start: 2021-03-01End: 2024-05-01Updated: 2024-07-31

A Study to Understand the Usage of an Artificial Intelligence Technology Called DARWEN for Eye Disorders and to Find Out the Factors Influencing Treatment Frequencies in People With nAMD and RVO

CompletedNCT06495203

BayerNeovascular Age-related Macular Degeneration, Retinal Vein Occlusion

Start: 2023-11-02End: 2024-02-29Updated: 2024-07-10

Evaluation of Serum- and OCT Biomarkers in Patients With DME Treated With Anti-VEGF or Dexamethasone Implant

RecruitingNCT06984822

Vastra Gotaland RegionDiabetes Mellitus, Diabetic Macular Edema, Hyperglycaemia (Diabetic) +4

Start: 2025-08-01End: 2028-12-31Target: 150Updated: 2025-11-21